© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 8, 630-631,
April 16, 2003
© 2003 Oxford University Press
CORRESPONDENCE |
Re: Views of American Oncologists About the Purposes of Clinical Trials
Affiliations of authors: B. D. Anderson, M. A. Smith, Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD; G. H. Reaman, Childrens Oncology Group, Bethesda, MD; E. D. Kodish, Childrens Oncology Group Bioethics Committee, Rainbow Babies and Childrens Hospital, Cleveland, OH.
Correspondence to: Barry D. Anderson, M.D., Ph.D., NCI-CTEP, 6130 Executive Blvd., EPN 7025, Rockville, MD 20852 (e-mail: andersonb@ctep.nci.nih.gov).
| The first 10% of the full text of this article appears below. |
In a recent article in the Journal, Joffe and Weeks (1) reported that most pediatric oncologists offered their patients the opportunity to enroll in trials to ensure that their patients received "state-of-the-art" therapy and that nearly 40% of responding pediatricians "reported that trials exist primarily to ensure state-of-the-art therapy for the participants